Your session is about to expire
← Back to Search
Procedure
Fetoscopic Repair for Gastroschisis
N/A
Recruiting
Led By Sundeep Keswani, MD
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during first month of life
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to test a new surgery for unborn babies with severe bowel issues where their intestines are outside their belly. The surgery is done through a small opening in the mother's womb using a camera and tiny tools. This method hopes to reduce complications after birth compared to traditional treatments.
Who is the study for?
This trial is for pregnant women over 18 with a single pregnancy between 20-25 weeks, where the fetus has gastroschisis. Candidates must have normal genetic tests and no significant unrelated anomalies or maternal health issues that could complicate surgery.
What is being tested?
The study is testing the safety and feasibility of repairing complex gastroschisis in unborn babies using fetoscopy—a surgical procedure performed on the fetus. The aim is to see if this can reduce death and complications after birth.
What are the potential side effects?
Potential side effects are not explicitly listed, but may include risks associated with fetal surgery such as preterm labor, infection, or complications from anesthesia.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at hospital discharge, an average of 1.5 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at hospital discharge, an average of 1.5 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Successful Repair of Complex Gastroschisis
Secondary study objectives
Bronchopulmonary Dysplasia
Central Line Associated Bloodstream Infection (CLABSI)
Intracranial hemorrhage
+13 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: fetoscopic surgical repairExperimental Treatment1 Intervention
Single arm study. All patients will receive the fetoscopic repair.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatment for Gastroschisis involves surgical repair, typically performed after birth, to return the exposed intestines to the abdominal cavity and close the abdominal wall defect. The trial studying fetoscopic surgical repair aims to perform this correction in utero, hypothesizing that early intervention can reduce postnatal mortality and morbidity.
This approach matters for Gastroschisis patients as it may prevent complications associated with prolonged exposure of the intestines to amniotic fluid, such as inflammation and damage, potentially leading to better overall outcomes and reduced need for extensive postnatal care.
Find a Location
Who is running the clinical trial?
Baylor College of MedicineLead Sponsor
1,024 Previous Clinical Trials
6,029,500 Total Patients Enrolled
Sundeep Keswani, MDPrincipal InvestigatorBaylor College of Medicine and Texas Children's Hospital
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My family and I have decided against ending the pregnancy before 24 weeks or standard treatment after birth.I do not have HIV or Hepatitis, or I have tested negative for these.I cannot have fetoscopic surgery due to issues like fibroids or uterine problems.I cannot have surgery due to a past uterine procedure or condition.My unborn baby has a significant health issue not related to gastroschisis.I have a health condition that makes surgery or anesthesia unsafe for me.I am a pregnant woman, 18 or older, and can consent for myself.My genetic tests show no significant abnormalities.I am not allergic to antibiotics like Gentamycin or Vancomycin.
Research Study Groups:
This trial has the following groups:- Group 1: fetoscopic surgical repair
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger